WFC — Wells Fargo & Company

Sentiment is constructive but not euphoric. The 12-month consensus price target is $98.14 and the fundamental narrative is positive, yet FMP's ratings breakdown (27 Buy / 29 Hold / 4 Sell) keeps the consensus label at Hold/Moderate Buy. As of 2026-08-27 the price is slightly below its 20- and 50-day moving averages, suggesting investors are waiting for Q3 2026 earnings to confirm the balance-sheet growth story before chasing the stock.

Revenue has clearly inflected. After a 2025 trough (Q1 2025 revenue down ~6% YoY to $29.6B), growth re-accelerated to +4.0% YoY in Q4 2025, +7.3% in Q1 2026, and +11.3% in Q2 2026 to $33.59B. Operating margin expanded from 21.3% in Q2 2025 to 24.0% in Q2 2026, and diluted EPS rose from $1.60 to $2.00 YoY. This is more than a one-off blip: cost discipline is structural (24 straight quarters of headcount declines) and asset-cap removal is allowing loan/deposit growth. The distorted Q4 2023 margin dip (operating margin 11.2%) was charge-related and not the trend.

As of 2026-08-27, WFC is neither cheap nor expensive. TTM P/E of 12.12x is in line with its 5-year average of 12.05x, P/S of 1.99x is slightly below its 5-year average of 2.02x, and P/B of 1.44x is reasonable for a bank with 17.7% ROTCE and improving returns. Forward P/E on consensus next-FY EPS of $7.289 is about 11.7x, so the market is not assigning a meaningful growth premium. PEG of 0.64 looks attractive only if double-digit EPS growth persists; otherwise the multiple is fair, not compelling.

At $84.97, the market is paying roughly 11.7x forward estimates—a 'show me' price rather than a boom-time valuation. If balance-sheet expansion and cost discipline push EPS above the ~$7.30 consensus, the stock can re-rate toward a 13x multiple and the $94–$98 zone. If credit costs rise or NII contracts, the low absolute multiple provides only modest cushion; the current price already reflects a normalization story, not a breakout.

As of 2026-08-27, RSI was 44.85 (neutral, no momentum); price was 2.09% below the 20-day SMA, 1.36% below the 50-day SMA, and 0.07% above the 200-day SMA. That is a range-bound/consolidation posture: the 200-day near $84.9 is the key support line, and reclaiming the 50-day would signal a momentum shift. There is no oversold setup yet, so patient buyers can wait for a base or a move above $87–$88.

• Fed rate trajectory and NII: rate cuts pressure loan yields, but deposit repricing may cushion bank margins.
• Post-asset-cap balance-sheet expansion: WFC can now grow loans, deposits, and trading assets without the old Fed cap.
• Consumer credit and employment cycle: rising unemployment or card/auto delinquencies would hurt credit quality.
• Regulatory environment: a completed stress test with a 2.5% SCB and the dividend hike signal reduced regulatory overhang.
• Bank-sector positioning: WFC's beta of 0.92 makes it a lower-volatility way to play a soft-landing/rate-normalization scenario.

• Q3 2026 earnings in mid-October: the first clear test of whether post-cap balance-sheet expansion converts into sustained top-line growth.
• Capital deployment: ongoing share buybacks and potential further dividend increases under the SCB framework.
• ROTCE durability: if WFC sustains 17%+ ROTCE, the market may grant a higher multiple.
• Net interest income stabilization and continued disciplined expense management.

• Credit deterioration: a recession or consumer stress would drive charge-offs and loan-loss provisions higher.
• NII compression from rate cuts: lower yields on floating-rate assets could outpace deposit repricing benefits.
• Execution risk on growth: growing the balance sheet aggressively could pressure capital ratios or underwriting standards.
• Valuation multiple cap: at 1.44x P/B and 12x earnings, the stock is not deep value; an EPS miss could compress it further.
• Residual regulatory/legacy issues, even after the asset cap removal and consent order closures.

WFC is a reasonable buy at $84.97 for a patient investor: roughly 11.7x forward earnings, a 2.12% yield, and a genuine earnings-growth setup as asset-cap headwinds turn into tailwinds. The main risks are cyclical—credit and NII—but the current price is not pricing perfection, and Q2 2026's 17.7% ROTCE suggests operating leverage is real.

Fair value of $94.76 is calculated by applying a 13.0x P/E multiple to consensus next-FY EPS of $7.289—a modest premium to WFC's 5-year average P/E of 12.05x, justified by the post-asset-cap growth inflection, 17.7% ROTCE, and cost discipline, but capped because bank multiples are sensitive to credit-cycle risk.